4//SEC Filing
Oxford Immunotec Global PLC 4
Accession 0001437749-16-027084
CIK 0001586049operating
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:00 PM ET
Size
6.6 KB
Accession
0001437749-16-027084
Insider Transaction Report
Form 4
Altieri Richard M.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2016-03-04+9,795→ 45,380 total - Award
Share Option (Right to Buy)
2016-03-04+40,812→ 40,812 totalExercise: $10.21Exp: 2026-03-04→ Ordinary Shares (40,812 underlying)
Footnotes (2)
- [F1]Option granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2017 through January 1, 2020.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001586049
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:00 PM ET
- Size
- 6.6 KB